Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rosiglitazone and cardiotoxicity--weighing the evidence.

Nathan DM. Rosiglitazone and cardiotoxicity--weighing the evidence. N Engl J Med. 2007 Jul 05; 357(1):64-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.